Amoxapine (or ASENDIN®) is mainly prescribed to treat major depressive disorder.
Class: Tricyclic (TCA), Tetracyclic (TeCA)
FDA Approval: 1989
Dosage Forms: 25 mg, 50 mg, 100 mg, 150 mg
Biological Half-life: 8-10 hours
Side Effects: Dizziness, dry mouth, constipation, nausea, anxiety, fatigue, blurred vision, confusion, headache, appetite changes, rash, weakness, tachycardia, nightmares, increased suicide risk
Routes of Administration: Oral
Pregnancy Category: C (US)